Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

Badve SV, Perkovic V, Jha V, Ramachandran R, Mushahar L, Menne J, De Vriese AS, Rossignol P, Flahault A, Al Ammari M, Skhiri H, Walsh M, Collister D, Liew A, Billot L, Bompoint S, Devaux A, Jun M, Lin E, Ramos da Cruz A, Ha JT, Eikelboom JW, Shaman A, Jardine MJ, Jesudason S, Wong MG, Anderson CS, Garg AX, Heerspink HJL, Monaghan H, Patel A, Mark PB, Wheeler DC, Lv J, Zuo L, Pilmore H, Gallagher M, TRACK Trial Investigators

Open source

DOI
10.1001/jama.2026.9379
Published
2026 Jul 28
Container
JAMA
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2026.9379,
  title = {Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.},
  author = {Badve SV and Perkovic V and Jha V and Ramachandran R and Mushahar L and Menne J and De Vriese AS and Rossignol P and Flahault A and Al Ammari M and Skhiri H and Walsh M and Collister D and Liew A and Billot L and Bompoint S and Devaux A and Jun M and Lin E and Ramos da Cruz A and Ha JT and Eikelboom JW and Shaman A and Jardine MJ and Jesudason S and Wong MG and Anderson CS and Garg AX and Heerspink HJL and Monaghan H and Patel A and Mark PB and Wheeler DC and Lv J and Zuo L and Pilmore H and Gallagher M and TRACK Trial Investigators},
  year = {2026},
  journal = {JAMA},
  doi = {10.1001/jama.2026.9379},
  url = {https://doi.org/10.1001/jama.2026.9379}
}

RIS

TY  - JOUR
TI  - Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.
AU  - Badve SV
AU  - Perkovic V
AU  - Jha V
AU  - Ramachandran R
AU  - Mushahar L
AU  - Menne J
AU  - De Vriese AS
AU  - Rossignol P
AU  - Flahault A
AU  - Al Ammari M
AU  - Skhiri H
AU  - Walsh M
AU  - Collister D
AU  - Liew A
AU  - Billot L
AU  - Bompoint S
AU  - Devaux A
AU  - Jun M
AU  - Lin E
AU  - Ramos da Cruz A
AU  - Ha JT
AU  - Eikelboom JW
AU  - Shaman A
AU  - Jardine MJ
AU  - Jesudason S
AU  - Wong MG
AU  - Anderson CS
AU  - Garg AX
AU  - Heerspink HJL
AU  - Monaghan H
AU  - Patel A
AU  - Mark PB
AU  - Wheeler DC
AU  - Lv J
AU  - Zuo L
AU  - Pilmore H
AU  - Gallagher M
AU  - TRACK Trial Investigators
PY  - 2026
JO  - JAMA
DO  - 10.1001/jama.2026.9379
UR  - https://doi.org/10.1001/jama.2026.9379
ER  - 

APA

SV, B., V, P., V, J., R, R., L, M., J, M., AS, D. V., P, R., A, F., M, A. A., H, S., M, W., D, C., A, L., L, B., S, B., A, D., M, J., E, L., A, R. D. C., JT, H., JW, E., A, S., MJ, J., S, J., MG, W., CS, A., AX, G., HJL, H., H, M., A, P., PB, M., DC, W., J, L., L, Z., H, P., M, G., & Investigators, T. T. (2026). Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.. JAMA. https://doi.org/10.1001/jama.2026.9379

Source records